| 注册
首页|期刊导航|中国药房|注射用单磷酸阿糖腺苷与阿昔洛韦注射液配伍稳定性考察

注射用单磷酸阿糖腺苷与阿昔洛韦注射液配伍稳定性考察

刘跃林

中国药房2016,Vol.27Issue(5):616-618,3.
中国药房2016,Vol.27Issue(5):616-618,3.DOI:10.6039/j.issn.1001-0408.2016.05.12

注射用单磷酸阿糖腺苷与阿昔洛韦注射液配伍稳定性考察

Compatible Stability of Vidarabine Monophosphate for Injection and Aciclovir Injection

刘跃林1

作者信息

  • 1. 如皋市中医院,江苏如皋 226500
  • 折叠

摘要

Abstract

OBJECTIVE:To investigate the stability of Vidarabine monophosphate for injection combined with Aciclovir injec-tion. METHODS:HPLC method was adopted. The content variations of two drugs in mixture were determined within 8 h at 5 ℃, 25℃,35℃under dark and light. The changes in appearance,property,pH value and insoluble particles(within 24 h)were inves-tigated before and after compatibility. RESULTS:There were no significant changes in appearance and pH value at 5 ℃,25 ℃, 35 ℃ under dark,and insoluble particles were in line with Chinese Pharmacopoeia(2010 edition),and the relative content of vida-rabine monophosphate and aciclovir were above 99%(compared with 0 h)within 8 h. Under the light conditions,as the tempera-ture raised and the extension of storage time,the content of vidarabine monophosphate did not significantly decrease,but that of aciclovir had declined significantly(4 h and after 4 h),while pH value also had a certain degree of rise;the insoluble particles had no obvious change. CONCLUSIONS:The mixture of vidarabine monophosphate and aciclovir in 0.9% Sodium chloride injections is stable under dark conditions within 8 h;it is suggested that the mixture should be used up within 4 h after mixing and protect from light to guarantee the safety of drug use in the clinic.

关键词

单磷酸阿糖腺苷/阿昔洛韦/配伍稳定性/高效液相色谱法

Key words

Vidarabine monophosphate/Aciclovir/Compatible stability/HPLC

分类

医药卫生

引用本文复制引用

刘跃林..注射用单磷酸阿糖腺苷与阿昔洛韦注射液配伍稳定性考察[J].中国药房,2016,27(5):616-618,3.

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文